RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
33 hedge funds and large institutions have $7.64M invested in Repros Therapeutics Inc. in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
33
Holding in Top 10
–
Calls
$575K
Puts
–
Top Buyers
1 | +$926K | |
2 | +$26K | |
3 | +$12.8K | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.9K |
5 |
Bank of America
Charlotte,
North Carolina
|
+$8.57K |
Top Sellers
1 | -$240K | |
2 | -$185K | |
3 | -$103K | |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$95K |
5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$68K |